First Page | Meta Content | |
---|---|---|
Document Date: 2006-08-03 11:40:31Open Document File Size: 359,96 KBShare Result on FacebookCityAbingdon / Groningen / Palo Alto / Sunderland / ONYX / Madison / Stratagene / /CompanyRS Coffin BioVex Ltd / Helena Biosciences / BioVex Ltd / Amersham / mCi / MCA / GM / /CountryNetherlands / United States / United Kingdom / /Currencypence / USD / /EventFDA Phase / /IndustryTermcancer therapy / culture media / cancer treatment / treatment of metastatic disease / treatment of cancer / therapy for cancer / antigen processing / /MedicalConditionartificially induced tumours / cancer therapy Introduction Oncolytic viruses / developed tumours / indicated xenograft tumours / strain / Injected tumours / Contralateral tumours / glioma / Fadu carcinoma / cold sores / metastatic disease / non-injected tumours / melanoma / cold sore / astrocytoma 48hr 48h / clinical and pre-clinical cancer / UK Herpes / adenocarcinoma 48hr / head and neck cancer / measles virus / MG Glioblastoma / cancer / disease / average tumor / oncolytic HSV BL Liu et al average tumor / lymphoma tumours / multi-modal cancer / tumour / sickness / A20 lymphoma tumours / liver cancer / human breast adenocarcinoma cells / infection / days Average tumor / herpes simplex virus / A20 tumours / GM-CSF expression A20 tumours / tumours / following infection / /MedicalTreatmentimmunization / chemotherapy / cancer therapy / Gene Therapy / Oncolytic virus therapy / /OrganizationUK HGMP Resource Centre / Gene Therapy Advisory Committee / /PersonMilton Park / /PositionRT / candidate for clinical development / /ProductSigma / ICP47À / /TechnologyGene Therapy / chemotherapy / treating cancer / gene delivery / recombination / /URLwww.nature.com/gt / /SocialTag |